Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA

Large Cap | Pharmaceuticals & Drugs

1847.30

12.90 (0.70%)

< Home < Back

Sun Pharmaceutical Industries informs about press release

Date: 06-10-2023

Sun Pharmaceutical Industries has informed that it enclosed Press Release relating to ‘Sun Pharma Announces US FDA Filing Acceptance of New Drug Application (NDA) For Deuruxolitinib’.

The above information is a part of company’s filings submitted to BSE.